Your browser doesn't support javascript.
loading
Targeting human langerin promotes HIV-1 specific humoral immune responses.
Kervevan, Jérôme; Bouteau, Aurélie; Lanza, Juliane S; Hammoudi, Adele; Zurawski, Sandra; Surenaud, Mathieu; Dieudonné, Lydie; Bonnet, Marion; Lefebvre, Cécile; Hocini, Hakim; Marlin, Romain; Guguin, Aurélie; Hersant, Barbara; Hermeziu, Oana; Menu, Elisabeth; Lacabaratz, Christine; Lelièvre, Jean-Daniel; Zurawski, Gerard; Godot, Véronique; Henri, Sandrine; Igyártó, Botond Z; Levy, Yves; Cardinaud, Sylvain.
Afiliação
  • Kervevan J; Vaccine Research Institute, Créteil, France, Inserm U955, Équipe 16, Créteil, France.
  • Bouteau A; Baylor Institute for Immunology Research (BIIR), Vaccine Research Institute, Dallas, Texas, United States of America.
  • Lanza JS; Institute of Biomedical Studies, Baylor University, Waco, Texas, United States of America.
  • Hammoudi A; Thomas Jefferson University, Department of Microbiology and Immunology, Philadelphia, Pennsylvania, United States of America.
  • Zurawski S; Centre d'Immunophénomique, Aix Marseille Université, INSERM, CNRS, Marseille, France.
  • Surenaud M; Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, INSERM, CNRS, Marseille, France.
  • Dieudonné L; Vaccine Research Institute, Créteil, France, Inserm U955, Équipe 16, Créteil, France.
  • Bonnet M; Baylor Institute for Immunology Research (BIIR), Vaccine Research Institute, Dallas, Texas, United States of America.
  • Lefebvre C; Vaccine Research Institute, Créteil, France, Inserm U955, Équipe 16, Créteil, France.
  • Hocini H; Vaccine Research Institute, Créteil, France, Inserm U955, Équipe 16, Créteil, France.
  • Marlin R; College of Biomedical and Life Sciences, University of Cardiff, Cardiff, United Kingdom.
  • Guguin A; Vaccine Research Institute, Créteil, France, Inserm U955, Équipe 16, Créteil, France.
  • Hersant B; Vaccine Research Institute, Créteil, France, Inserm U955, Équipe 16, Créteil, France.
  • Hermeziu O; CEA, Université Paris-Sud, Inserm, U1184 "Immunology of Viral Infections and Autoimmune Diseases" (IMVA), IDMIT Department, IBFJ, Fontenay-aux-Roses, France.
  • Menu E; Inserm U955 -Plateforme de Cytométrie, Institut Mondor de Recherche Biomédicale, UPEC, Créteil, France.
  • Lacabaratz C; Department of plastic and maxillo-facial surgery, Henri Mondor Hospital, Créteil, France.
  • Lelièvre JD; Department of plastic and maxillo-facial surgery, Henri Mondor Hospital, Créteil, France.
  • Zurawski G; CEA, Université Paris-Sud, Inserm, U1184 "Immunology of Viral Infections and Autoimmune Diseases" (IMVA), IDMIT Department, IBFJ, Fontenay-aux-Roses, France.
  • Godot V; MISTIC Group, Department of Virology, Institut Pasteur, Paris, France.
  • Henri S; Vaccine Research Institute, Créteil, France, Inserm U955, Équipe 16, Créteil, France.
  • Igyártó BZ; Vaccine Research Institute, Créteil, France, Inserm U955, Équipe 16, Créteil, France.
  • Levy Y; Baylor Institute for Immunology Research (BIIR), Vaccine Research Institute, Dallas, Texas, United States of America.
  • Cardinaud S; Vaccine Research Institute, Créteil, France, Inserm U955, Équipe 16, Créteil, France.
PLoS Pathog ; 17(7): e1009749, 2021 07.
Article em En | MEDLINE | ID: mdl-34324611
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígenos CD / Células de Langerhans / HIV-1 / Vacinas contra a AIDS / Lectinas Tipo C / Lectinas de Ligação a Manose / Imunidade Humoral Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígenos CD / Células de Langerhans / HIV-1 / Vacinas contra a AIDS / Lectinas Tipo C / Lectinas de Ligação a Manose / Imunidade Humoral Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article